Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 6,140 shares at $798.42 ($4.9M) on 2023-04-21, disclosed to the SEC on 2023-04-24.
Scheduled sale ($4.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $798.42 | 3,070 | $2.5M | 50.0% |
| 2 | $798.42 | 3,070 | $2.5M | 50.0% |
| Total | $798.42 avg | 6,140 | $4.9M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |
| REGN | SELL | 2023-01-30 | $747 | — | Filing → |